Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FUSN |
---|---|---|
09:32 ET | 4856 | 21.3 |
09:34 ET | 814 | 21.32 |
09:39 ET | 600 | 21.29 |
09:43 ET | 100 | 21.28 |
09:45 ET | 518 | 21.28 |
09:50 ET | 200 | 21.27 |
09:52 ET | 304 | 21.2702 |
09:56 ET | 851 | 21.28 |
09:57 ET | 707 | 21.27 |
09:59 ET | 100 | 21.27 |
10:01 ET | 200 | 21.26 |
10:03 ET | 2152 | 21.28 |
10:06 ET | 300 | 21.2718 |
10:08 ET | 800 | 21.27 |
10:12 ET | 1500 | 21.25 |
10:14 ET | 10549 | 21.26 |
10:15 ET | 3290 | 21.25 |
10:19 ET | 400 | 21.24 |
10:24 ET | 100 | 21.24 |
10:26 ET | 300 | 21.24 |
10:28 ET | 9839 | 21.23 |
10:30 ET | 100 | 21.22 |
10:32 ET | 4059 | 21.23 |
10:33 ET | 93515 | 21.226 |
10:37 ET | 800 | 21.22 |
10:42 ET | 2596 | 21.22 |
10:44 ET | 1600 | 21.22 |
10:46 ET | 1000 | 21.22 |
10:48 ET | 300 | 21.22 |
10:50 ET | 7240 | 21.24 |
10:51 ET | 284 | 21.24 |
10:53 ET | 400 | 21.245 |
10:55 ET | 600 | 21.25 |
10:57 ET | 901 | 21.2326 |
11:02 ET | 100 | 21.24 |
11:04 ET | 500 | 21.23 |
11:06 ET | 500 | 21.236 |
11:08 ET | 1258 | 21.24 |
11:09 ET | 9614 | 21.26 |
11:11 ET | 2004 | 21.28 |
11:13 ET | 100 | 21.28 |
11:15 ET | 437 | 21.29 |
11:18 ET | 200 | 21.29 |
11:20 ET | 400 | 21.285 |
11:24 ET | 400 | 21.29 |
11:26 ET | 300 | 21.28 |
11:27 ET | 980 | 21.26 |
11:29 ET | 150 | 21.27 |
11:31 ET | 100 | 21.26 |
11:36 ET | 400 | 21.26 |
11:38 ET | 100 | 21.27 |
11:44 ET | 573 | 21.27 |
11:49 ET | 200 | 21.255 |
11:51 ET | 100 | 21.26 |
11:54 ET | 400 | 21.25 |
11:56 ET | 100 | 21.26 |
11:58 ET | 200 | 21.26 |
12:00 ET | 100 | 21.26 |
12:05 ET | 500 | 21.2522 |
12:07 ET | 2977 | 21.24 |
12:09 ET | 1071 | 21.25 |
12:12 ET | 100 | 21.27 |
12:14 ET | 100 | 21.27 |
12:18 ET | 100 | 21.27 |
12:21 ET | 200 | 21.2601 |
12:23 ET | 100 | 21.26 |
12:25 ET | 400 | 21.26 |
12:27 ET | 700 | 21.25 |
12:30 ET | 200 | 21.25 |
12:32 ET | 200 | 21.25 |
12:34 ET | 250 | 21.26 |
12:36 ET | 1635 | 21.25 |
12:38 ET | 300 | 21.24 |
12:41 ET | 100 | 21.24 |
12:43 ET | 4866 | 21.25 |
12:50 ET | 100 | 21.24 |
12:52 ET | 900 | 21.25 |
12:54 ET | 2223 | 21.25 |
12:56 ET | 221 | 21.2507 |
01:03 ET | 100 | 21.26 |
01:06 ET | 600 | 21.25 |
01:08 ET | 700 | 21.245 |
01:19 ET | 590 | 21.245 |
01:24 ET | 100 | 21.245 |
01:26 ET | 1100 | 21.25 |
01:28 ET | 708 | 21.25 |
01:32 ET | 5600 | 21.25 |
01:33 ET | 1000 | 21.26 |
01:35 ET | 1200 | 21.2503 |
01:37 ET | 200 | 21.26 |
01:42 ET | 130 | 21.255 |
01:44 ET | 400 | 21.26 |
01:46 ET | 800 | 21.25 |
01:51 ET | 200 | 21.255 |
01:53 ET | 2049 | 21.2483 |
01:55 ET | 637 | 21.2402 |
01:57 ET | 2551 | 21.24 |
02:02 ET | 413 | 21.27 |
02:04 ET | 700 | 21.255 |
02:06 ET | 300 | 21.26 |
02:11 ET | 300 | 21.26 |
02:13 ET | 500 | 21.25 |
02:15 ET | 100 | 21.25 |
02:20 ET | 100 | 21.24 |
02:24 ET | 100 | 21.24 |
02:26 ET | 100 | 21.25 |
02:27 ET | 700 | 21.2499 |
02:29 ET | 100 | 21.24 |
02:31 ET | 710 | 21.2407 |
02:33 ET | 700 | 21.245 |
02:36 ET | 200 | 21.24 |
02:40 ET | 100 | 21.245 |
02:44 ET | 3947 | 21.25 |
02:47 ET | 7447 | 21.26 |
02:51 ET | 643 | 21.25 |
02:54 ET | 1486 | 21.245 |
02:56 ET | 2163 | 21.24 |
02:58 ET | 200 | 21.24 |
03:02 ET | 100 | 21.245 |
03:03 ET | 800 | 21.25 |
03:07 ET | 900 | 21.245 |
03:09 ET | 288 | 21.245 |
03:12 ET | 100 | 21.24 |
03:16 ET | 624 | 21.24 |
03:18 ET | 7283 | 21.245 |
03:20 ET | 100 | 21.24 |
03:23 ET | 200 | 21.24 |
03:25 ET | 100 | 21.245 |
03:27 ET | 332 | 21.245 |
03:30 ET | 200 | 21.24 |
03:32 ET | 400 | 21.245 |
03:34 ET | 1309 | 21.245 |
03:36 ET | 300 | 21.245 |
03:38 ET | 100 | 21.24 |
03:39 ET | 974 | 21.24 |
03:41 ET | 1630 | 21.24 |
03:45 ET | 2006 | 21.24 |
03:48 ET | 500 | 21.24 |
03:50 ET | 990 | 21.24 |
03:52 ET | 13309 | 21.25 |
03:54 ET | 45843 | 21.24 |
03:56 ET | 3565 | 21.24 |
03:57 ET | 8762 | 21.24 |
03:59 ET | 34553 | 21.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fusion Pharmaceuticals Inc | 1.8B | -14.5x | --- |
Syndax Pharmaceuticals Inc | 1.8B | -7.0x | --- |
Structure Therapeutics Inc | 1.8B | -14.8x | --- |
Sana Biotechnology Inc | 1.8B | -5.6x | --- |
Neumora Therapeutics Inc | 1.7B | -4.5x | --- |
Inhibrx Inc | 1.6B | -6.9x | --- |
Fusion Pharmaceuticals Inc. is a clinical-stage oncology company. The Company is focused on developing radiopharmaceuticals as precision medicines. It has developed its Targeted Alpha Therapies (TAT), platform to enable it to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha particle payloads to tumors. The TAT platform is underpinned by its ability to radiolabel various classes of targeting molecules, its research and insights into the underlying chemistry and biology of alpha emitting radiopharmaceuticals, its differentiated capabilities in target identification, candidate generation, manufacturing and supply chain, its Fast-Clear linker technology used in conjunction with antibody-based targeting molecules, and development of imaging agents. Its clinical portfolio includes FPI-2265, FPI-1434 and FPI-2059. FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer in a Phase 2 trial.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
---|---|
Revenue (TTM) | $2.1M |
Shares Outstanding | 84.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.69 |
EPS | $-1.47 |
Book Value | $2.79 |
P/E Ratio | -14.5x |
Price/Sales (TTM) | 870.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,798.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.